Anavex Life Sciences Corp (AVXL)

[nidan7500]

georgejji

Expect the Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled 48-week Safety and Efficacy Trial of ANAVEX2-73 for the Treatment of Early Alzheimer's Disease (AD) to complete recruitment by or before the end of April 2021.

Curious if there is any acceleration (as in physics) factor WS sp where a reaction from market buying causes even more interest in more buying. The comparison to Boeing 787 battery failures a while back comes to mind, known as thermal runaway, where something in physics gets hotter b/c it is getting hotter. Can there be such a thing as market (sp) runaway as the target gets closer to sp goes vertical?

In AVXL AD case the risk of ownership is continuously mitigated as MOA all trials Trifecta data accumulates, etc. Will alert buyers start to come out of the woodwork driving sp up even before results are published b/c cumulative actions taken by AVXL staff make outcome almost a certainty? Not the typical FDA last second drama scenario b/c the work is done while pass/fail scenario is predictable w/confidence approaching certainty.

Just saying.